Thanks to their anti-inflammatory action through different mechanisms, GLP1-RA may provide, in a selected cohort of patients, the cardiovascular protection desired with targeted therapies, but without the wide side-effects of those drugs
Semaglutide is a GLP-1 agonist, Tirzepatide is a dual GLP-1 and GIP agonist, and Retatrutide is a triple GLP-1, GIP, and glucagon agonist
Plan ahead for procedures
The cleanest way to hold the difference in mind is to count hormonal axes and ask what each does to the energy-balance equation
Pharmacist-led medication review at GLP-1 receptor agonist initiation: impact on drug interaction identification
As of now, research on small molecule GLP-1RAs is still mainly in the laboratory and early clinical trial stages